Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2012

Hagen JW, Magro CM, A Crowson N. Emerging adverse cutaneous drug reactions. Dermatol Clin. 2012;30(4):695-730, vii.

Sawai CM, Freund J, Oh P, Ndiaye-Lobry D, Bretz JC, Strikoudis A, et al. Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. Cancer Cell. 2012;22(4):452-65.

Webber A, Hambleton J, Chami A, Bang H, Seshan S, Sharma A, et al. Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction. Transplantation. 2012;93(1):54-60.

Dunne WM, Westblade LF, Ford B. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis. 2012;31(8):1719-26.

Berman DM, Bosenberg MW, Orwant RL, Thurberg BL, Draetta GF, Fletcher CD, et al. Investigative pathology: leading the post-genomic revolution. Lab Invest. 2012;92(1):4-8.

Weiss SA, Pisapia D, Mayer SA, Willey JZ, Lee K. Amyloid β-Related Angiitis Causing Coma Responsive to Immunosuppression. Case Rep Pathol. 2012;2012:678746.

Cheng M, Quail MR, Gingrich DE, Ott GR, Lu L, Wan W, et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 2012;11(3):670-9.

Geetha T, Zheng C, McGregor WC, B White D, Diaz-Meco MT, Moscat J, et al. TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor. Neurochem Int. 2012;61(8):1289-93.

Martin P, Moscat J. Th1/Th2 Differentiation and B Cell Function by the Atypical PKCs and Their Regulators. Front Immunol. 2012;3:241.

Goyal A, Jhala N, Gupta P. TeleCyP (Telecytopathology): real-time fine-needle aspiration interpretation. Acta Cytol. 2012;56(6):669-77.